The Board of Directors of AXISCADES Technologies Limited, based on the recommendation of the Nomination and Remuneration Committee, approved the grant of 2,46,340 stock options to eligible employees of the Company under AXISCADES ESOP 2018 - Series 1 & 2. The approval was granted through a circular resolution passed on October 27, 2026.
Key ESOP Details:
- Total number of stock options granted: 2,46,340
- Exercise price: ₹1,440 per share (Rupees One Thousand Four Hundred and Forty only)
- Each stock option entitles the grantee to apply for one equity share of the Company upon exercise
- Vesting schedule: Options will vest in accordance with the vesting schedule set out in the Grant letter
- Exercise period: 8 years from the date of grant (October 27, 2026)
- Scheme compliance: Yes, in terms of SEBI (Share Based Employees Benefits and Sweat Equity) Regulations, 2021
Regulatory Compliance:
- Disclosure made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- Compliance with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, last updated on January 30, 2026
- The information will be available on the Company's website
Company Information:
- CIN No.: L72200KA1990PLC084435
- Contact: Ph: +91 80 4193 9000 | Fax: +91 80 4193 9099 | Email: info@axiscades.com
Additional Announcements:
No additional corporate updates were included in this filing beyond the ESOP grant intimation.